| Dokumendiregister | Terviseamet |
| Viit | 13.2-7/24/4904-1 |
| Registreeritud | 07.05.2024 |
| Sünkroonitud | 08.05.2024 |
| Liik | Sissetulev dokument |
| Funktsioon | 13.2 Nakkushaiguste labor |
| Sari | 13.2-7 NHL kirjavahetus |
| Toimik | 13.2-7/2024 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | WHO |
| Saabumis/saatmisviis | WHO |
| Vastutaja | Oksana Joamets (TA, Peadirektori asetäitja (2) vastutusvaldkond, Rahvatervise labor, Nakkushaiguste labor) |
| Originaal | Ava uues aknas |
From: "SAXENTOFF, Eugene Victor" <[email protected]>
Sent: Tue, 07 May 2024 09:21:26 +0000
To: Undisclosed recipients:;
Subject: FW: Request for Member State feedback on the draft evaluation of tOPV-bOPV switch
|
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear colleagues, members of the WHO European Polio Laboratory Network,
For your information, please see below the call for feedback on the draft evaluation of tOPV-bOPV switch that was shared with our counterparts in the countries.
Best regards,
Eugene Saxentoff
IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information.
If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please dispose
of and delete this transmission.
P Please consider the environment before printing
From: WHO Europe Vaccine-preventable Diseases and Immunization Programme <[email protected]>
Sent: 07 May 2024 11:15
Subject: Request for Member State feedback on the draft evaluation of tOPV-bOPV switch
Dear colleagues,
In 2023, the GPEI Strategy Committee commissioned an external evaluation of the 2016 global withdrawal of Sabin poliovirus type 2 (OPV2) and switch from trivalent oral polio vaccine (tOPV) to bivalent OPV (bOPV). The evaluation aims to generate critical lessons learned from the OPV2 withdrawal, in order to guide the direction of the GPEI (including future OPV withdrawal efforts) and secure a world free of all polioviruses.
To ensure the evaluation is as relevant and useful as possible, and to provide the public health community and other interested stakeholders the opportunity to contribute, the lessons learned team is soliciting thoughts, comments and suggestions on the public draft for consultation. Interested stakeholders and members of the public health community are invited to share any contributions, ideas or suggestions by Friday 10 May 2024, to: [email protected]. Final publication of the evaluation is anticipated shortly after this public consultation. The public draft for consultation together with its annexes are available here.
Kind regards,
Vaccine-preventable Diseases & Immunization (VPI)
World Health Organization Regional Office for Europe